| View |
|
DR-XY48705
|
Zinc
|
RemZnc
|
20 mg (equivalent to 57.645 mg Zinc Sulfate Monohydrate)
|
Tablet
|
-
|
The IBN Sina Pharmaceutical Industry Ltd.
|
Bangladesh
|
Initial [OTC]
|
20 April 2023
|
20 April 2028
|
| View |
|
DRMO-94
|
Medical Grade Oxygen
|
None
|
None
|
None
|
-
|
Atame Trading Corporation
|
Philippines
|
Initial
|
25 April 2023
|
25 April 2028
|
| View |
|
DRP-13810
|
Cetrorelix (as acetate)
|
None
|
250 mcg
|
Lyophilized Powder for Injection (S.C.)
|
-
|
Gufic Biosciences Limited
|
India
|
Initial
|
26 April 2023
|
26 April 2028
|
| View |
|
DRP-13789
|
Ofloxacin
|
Optiquin
|
3 mg/mL
|
Ophthalmic Solution (Eye Drops)
|
-
|
Opal Laboratories (Pvt.) Limited.
|
Pakistan
|
Initial
|
20 April 2023
|
20 April 2028
|
| View |
|
DRP-13812
|
Cetrorelix (as acetate)
|
Cetrothix
|
250 mcg
|
Lyophilized Powder for Injection (S.C.)
|
-
|
Gufic Biosciences Limited
|
India
|
Initial
|
26 April 2023
|
26 April 2028
|
| View |
|
DRP-13813
|
Cetrorelix (as acetate)
|
Cetlix
|
250 mcg
|
Lyophilized Powder for Injection (S.C.)
|
-
|
Gufic Biosciences Limited
|
India
|
Initial
|
26 April 2023
|
26 April 2028
|
| View |
|
DRP-13832
|
Metoclopramide
|
Saphclomide
|
10 mg
|
Film-Coated Tablet
|
-
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
Initial
|
26 April 2023
|
26 April 2028
|
| View |
|
BR-893
|
Alglucosidase alfa
|
Myozyme
|
50 mg
|
Powder For Concentrate For Solutions For Infusion (IV)
|
-
|
Genzyme Ireland Limited
|
Ireland
|
Renewal
|
26 April 2023
|
31 January 2028
|
| View |
|
DRHR-2238
|
Menthol + Methyl Salicylate + Eucalyptus Oil + Camphor
|
None
|
232.5 mg/186 mg/27.9 mg/27.9 mg per mL
|
Medicated Oil
|
-
|
Leung Kai Fook Medical Co Pte Ltd.
|
Singapore
|
Initial
|
25 April 2023
|
25 April 2025
|
| View |
|
DRP-13802
|
Sugammadex (as sodium)
|
Sogoma 500
|
100 mg/mL
|
Solution for Injection (IV)
|
-
|
Aspiro Pharma Limited
|
India
|
Initial
|
27 April 2023
|
27 April 2028
|
| View |
|
DRP-13801
|
Sugammadex (as sodium)
|
Sogoma 200
|
100 mg/mL
|
Solution for Injection (IV)
|
-
|
Aspiro Pharma Limited
|
India
|
Initial
|
27 April 2023
|
27 April 2028
|
| View |
DRP-13782_PI_01.pdf
|
DRP-13782
|
Vincristine Sulfate
|
Rasteo
|
1 mg/mL
|
Solution for Injection (I.V.)
|
-
|
PT Sanbe Farma (Unit 3)
|
Indonesia
|
Initial
|
19 April 2023
|
19 April 2028
|
| View |
|
DRP-13768
|
Ascorbic Acid + Zinc
|
Corbizee Plus FC
|
1 g (equivalent to 1.125 g Sodium Ascorbate)/35 mg (equivalent to 96.071 mg Zinc Sulfate Monohydrate)
|
Film-Coated Tablet
|
-
|
Lifesquare Laboratories Inc.
|
Philippines
|
Initial
|
17 April 2023
|
17 April 2028
|
| View |
|
HRP-592
|
Isopropyl Alcohol
|
Evergreen
|
70% (v/v)
|
Solution with Moisturizer (Bamboo Essence
Scent)
|
-
|
ACE Pharmaceuticals, Inc.
|
Philippines
|
Initial
|
17 April 2023
|
17 April 2025
|
| View |
|
DRP-13756
|
Ascorbic Acid + Zinc
|
Cgen Plus ChewTab
|
250 mg (equivalent to 281.25mg Sodium Ascorbate)/ 15mg (equivalent to 105mg Zinc Gluconate)
|
Chewable Tablet
|
-
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
Initial [OTC]
|
13 April 2023
|
13 April 2028
|
| View |
|
DRP-13787
|
Ascorbic Acid + Zinc
|
Cgen Plus Chewable
|
250 mg (equivalent to 281.25mg Sodium Ascorbate)/ 10 mg (equivalent to 70mg Zinc Gluconate)
|
Chewable Tablet
|
-
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
Initial [OTC]
|
20 April 2023
|
20 April 2028
|
| View |
|
DRP-13755
|
Ascorbic Acid + Zinc
|
Cgen Plus CT
|
250 mg (equivalent to 281.25mg Sodium Ascorbate)/
5 mg (equivalent to 35 mg Zinc Gluconate)
|
Chewable Tablet
|
-
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
Initial [OTC]
|
13 April 2023
|
13 April 2028
|
| View |
|
DRP-13788
|
Ascorbic Acid + Zinc
|
Rapcvit Plus Teens
|
250 mg (equivalent to 281.25mg Sodium Ascorbate)/ 10 mg (equivalent to 70 mg Zinc Gluconate)
|
Chewable Tablet
|
-
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
Initial |OTC]
|
20 April 2023
|
20 April 2028
|
| View |
|
DRP-13836
|
Letrozole
|
Letrosaph
|
2.5 mg
|
Film-Coated Tablet
|
-
|
Bruck Pharma Private Limited
|
India
|
Initial [Reconstruction]
|
27 April 2023
|
08 February 2028
|
| View |
|
DRP-10870
|
Mometasone Furoate
|
Novatasone
|
1 mg/g (0.1% w/w)
|
Topical Cream
|
-
|
Blossom Pharmaceuticals
|
India
|
Initial
|
09 December 2021
|
09 December 2026
|